T-1105 - CAS 55321-99-8
Catalog: |
BB029001 |
Product Name: |
T-1105 |
CAS: |
55321-99-8 |
Synonyms: |
3,4-Dihydro-3-oxo-2-pyrazinecarboxamide; 3-Hydroxypyrazinamide; 3-Hydroxy-2-pyrazinecarboxamide; NSC 163503; 3-Hydroxypyrazine-2-carboxamide; 3-Oxo-3,4-dihydropyrazine-2-carboxamide; 3-Hydroxypyrazine-2-carboxylic acid amide; Pyrazinecarboxamide, 3,4-dihydro-3-oxo- |
IUPAC Name: | 2-oxo-1H-pyrazine-3-carboxamide |
Description: | T-1105, a structural analogue of T-705, is a broad-spectrum viral polymerase inhibitor that inhibits RNA viral polymerase after conversion to a ribonucleoside triphosphate (RTP) metabolite. It shows antiviral activity against various RNA viruses, including Zika virus (ZIKV), influenza virus, arenaviruses, bunyaviruses, West Nile virus (WNV), yellow fever virus (YFV) and foot-and-mouth disease virus (FMDV). It can be formed by nicotinamide mononucleotide adenylyltransferase. |
Molecular Weight: | 139.11 |
Molecular Formula: | C5H5N3O2 |
Canonical SMILES: | C1=CN=C(C(=O)N1)C(=O)N |
InChI: | InChI=1S/C5H5N3O2/c6-4(9)3-5(10)8-2-1-7-3/h1-2H,(H2,6,9)(H,8,10) |
InChI Key: | SZPBAPFUXAADQV-UHFFFAOYSA-N |
Boiling Point: | 640.8±55.0°C at 760 mmHg |
Melting Point: | >182°C (dec.) |
Purity: | ≥96% |
Density: | 1.63±0.1 g/cm3 (Predicted) |
Solubility: | Soluble in DMSO (Slightly), Aqueous Base (Slightly) |
Appearance: | Pale Brown to Brown Solid |
Storage: | Store at 2-8°C under inert atmosphere |
MDL: | MFCD00233977 |
LogP: | -0.01860 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113461622-A | Synthesis method of Favipiravir intermediate 6-bromo-3-hydroxypyrazine-2-formamide | 20210811 |
CN-113121457-A | Synthesis process of Favipiravir intermediate 3, 6-dichloro-2-cyanopyrazine | 20210423 |
CN-112851589-A | Preparation method of Favipiravir intermediate 6-bromo-3-hydroxypyrazine-2-formamide | 20210125 |
CN-111662938-A | Application of nitrile hydratase in catalyzing hydration reaction of cyanopyrazine compound to generate amide pyrazine compound | 20200623 |
CN-111704582-A | Preparation method of Favipiravir and derivatives thereof | 20200623 |
PMID | Publication Date | Title | Journal |
19428599 | 20090601 | T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections | Antiviral research |
Complexity: | 241 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 139.038176411 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 139.038176411 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 84.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[34374-88-4]
2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde
-
[80935-59-7]
(Benzene-1,3,5-triyl)triacetonitrile
-
[7194-86-7]
Nonatriacontane
-
[63089-56-5]
4-Amino-1,2,3,5,6,7-hexahydro-s-indacene
-
[1211537-07-3]
6-Chloro-3-methylpicolinaldehyde
-
[72914-19-3]
4,4'-Di-tert-butyl-2,2'-dipyridyl
INDUSTRY LEADERS TRUST OUR PRODUCTS